Lipohypertrophy
What the FDA labels record as adverse events, each one tied back to the evidence it came from.
What is Lipohypertrophy?
Thickened, swollen fat at a site injected over and over.
The damaged tissue absorbs the drug erratically, so appetite suppression and results become unpredictable, and people often read that as the drug failing. Rotate at least two inches between doses, cycling abdomen, thigh and upper arm across about eight weeks.
Injection-site rotation cheat sheet →
GLP Watchdog writes these definitions from FDA labels and peer-reviewed PubMed literature.
Where Lipohypertrophy comes up on this site
On GLP Watchdog, Lipohypertrophy comes up in 1 research article.
Research that discusses it
Other terms under Side effects
Where the evidence lives
- The full GLP-1 glossary (150 terms, 8 categories)
- Research articles — written from primary sources
- Tools and calculators
- Compare GLP-1 telehealth providers